Methuselah Foundation Adds 1M to the Liquidity Pools for $ELON

Methuselah Foundation, the largest holder of $ELON in the universe, is inaugurating an ELON/USDC trading pair in the amount of $1 million to recognize the organization’s latest initiative.

The ELON/USDC trading pair will be listed on Uniswap v3, one of the most popular cryptocurrency decentralized exchanges (DEXs).

The trading pair was inaugurated to recognize the pending launch of an Animal-Free Precision Medicine Challenge, in which winning teams will share $1 million in prizes. The Foundation-backed competition is designed to encourage development of new technologies to replace animal testing in the drug discovery process. It aims to attract competing teams to create technology that is more accurate than current animal models and will ultimately be as good as human trials.

"The Animal-Free Precision Medicine prize is part of the Foundation’s mission to benefit humanity, by making drug discovery more efficient and cost effective,” said Foundation CEO David Gobel. “Because we are tackling this mission in cooperation with the Dogelon Mars community, we felt it appropriate to create an ELON/USDC trading pair in the amount of $1 million – the value of the Challenge prize.”

Methuselah Foundation is inaugurating an ELON/USDC trading pair in the amount of $1 million to recognize the organization’s latest initiative, which supports broader use of Animal Free Precision Medicine. The illustration above shows how animal-free testing will evolve in coming years.

Gobel has previously proclaimed the $ELON a “mission token” that brings the Dogelon Mars community together around a singular objective: Reduce human suffering and extend the healthy human lifespan, while advancing humanity’s adventure on earth and in space, with the enthusiastic support of the rapidly growing Dogelon Mars community.

The community has responded enthusiastically by committing their meme tokens to fund scientific advances. For example, it recently funded the transportation of experiments to the International Space Station, to test astronauts’ ability to bio-print replacement organ tissue in space. The experiment’s results will help to develop medical solutions for crews spending years away from Earth on deep-space missions.